Solarea Bio
Solaria Bio
Cambridge, United States · $15.0M raised
- Headquarters
- Cambridge, Massachusetts
- Website
- solareabio.com
- Total Funding
- $15.0M
- Last Round
- $15.0M Series BMay 2023
- Rounds
- 1
About
Clinical-stage biotech translating plant-microbiome science into microbial therapeutics for age-related inflammatory conditions such as joint health.
Summary
Solarea Bio is a Biotech company based in Cambridge, United States. It has raised $15.0M in total across 1 round, most recently a $15.0M Series B round in May 2023. Investors include S2G Ventures, Bold Capital Partners and Viking Global.
Tech & App Stack
6 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
May 2023
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Altos Labs combines academic science and industry development to create medicines that restore ce...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/solarea-bio"><img src="https://indexed.vc/api/badge/company/solarea-bio" alt="Solarea Bio on Indexed.vc" width="260" height="76" /></a>